Doing Well by Doing Good

Together with the Global Health Technologies Coalition, we publish a report examining how US federal funding for global health R&D is delivering impact both in the US and abroad.

The report details funding trends over the past 16 years from the US government investment in R&D for neglected diseases; emerging infectious diseases, including COVID-19; and sexual and reproductive health issues. It quantifies the impact of this support in advancing new technologies to approval and a burgeoning pipeline of potential products for neglected and non-COVID emerging infectious diseases, with individual case studies on the impact of US-supported innovations. The report also examines the broader returns from these investments, including how they drive improved research capacity and economic development in low- and middle-income countries and directly benefit the US economy by creating jobs, stimulating industry investment, and contributing multiplied impact to the economy relative to their congressional appropriations.